Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M12,474Revenue $M3,324Net Margin (%)8.6Z-Score3.5
Enterprise Value $M12,879EPS $3.8Operating Margin %24.1F-Score6
P/E(ttm))45.8Cash Flow Per Share $8.0Pre-tax Margin (%)13.4Higher ROA y-yN
Price/Book7.110-y EBITDA Growth Rate %11.2Quick Ratio1.8Cash flow > EarningsY
Price/Sales3.85-y EBITDA Growth Rate %8.5Current Ratio2.3Lower Leverage y-yY
Price/Cash Flow12.2y-y EBITDA Growth Rate %-52.8ROA % (ttm)5.7Higher Current Ratio y-yN
Dividend Yield %0.5Insider Buy (3m)0ROE % (ttm)15.7Less Shares Outstanding y-yY
Payout Ratio %23.0Shares Outstanding M74.3ROI % (ttm)5.1Gross Margin Increase y-yY

Gurus Latest Trades with BCR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BCRDonald Yacktman 2015-03-31 Reduce-0.79%$164.52 - $178.59
($171.43)
$ 168.01-2%Reduce -25.34%3,326,670
BCRYacktman Fund 2015-03-31 Reduce-0.75%$164.52 - $178.59
($171.43)
$ 168.01-2%Reduce -25.10%1,570,000
BCRYacktman Focused Fund 2015-03-31 Reduce-0.71%$164.52 - $178.59
($171.43)
$ 168.01-2%Reduce -24.41%1,220,000
BCRYacktman Fund 2014-12-31 Reduce-1.42%$144.77 - $172.68
($161.89)
$ 168.014%Reduce -35.51%2,096,000
BCRDonald Yacktman 2014-12-31 Reduce-1.17%$144.77 - $172.68
($161.89)
$ 168.014%Reduce -30.85%4,455,796
BCRYacktman Focused Fund 2014-12-31 Reduce-0.82%$144.77 - $172.68
($161.89)
$ 168.014%Reduce -24.93%1,614,000
BCRRobert Olstein 2014-12-31 Sold Out -0.63%$144.77 - $172.68
($161.89)
$ 168.014%Sold Out0
BCRJoel Greenblatt 2014-12-31 Reduce-0.31%$144.77 - $172.68
($162.11)
$ 168.014%Reduce -93.82%14,178
BCRVanguard Health Care Fund 2014-12-31 Reduce-0.05%$144.77 - $172.68
($161.99)
$ 168.014%Reduce -12.16%912,700
BCRJoel Greenblatt 2014-09-30 Add0.27%$142.3 - $153.13
($147.81)
$ 168.0112%Add 470.83%229,325
BCRYacktman Focused Fund 2014-09-30 Reduce-0.22%$142.3 - $153.13
($147.81)
$ 168.0112%Reduce -6.52%2,150,000
BCRDonald Yacktman 2014-09-30 Reduce-0.15%$142.3 - $153.13
($147.81)
$ 168.0112%Reduce -3.85%6,443,334
BCRYacktman Fund 2014-09-30 Reduce-0.1%$142.3 - $153.13
($147.7)
$ 168.0112%Reduce -2.40%3,250,000
BCRRobert Olstein 2014-09-30 Reduce-0.08%$142.3 - $153.13
($147.7)
$ 168.0112%Reduce -10.53%34,000
BCRVanguard Health Care Fund 2014-09-30 Reduce-0.04%$142.3 - $153.13
($147.7)
$ 168.0112%Reduce -10.22%1,039,100
BCRVanguard Health Care Fund 2014-06-30 Reduce-0.28%$136.23 - $149.25
($142.86)
$ 168.0115%Reduce -37.07%1,157,400
BCRRobert Olstein 2014-06-30 Add0.15%$136.23 - $149.25
($142.86)
$ 168.0115%Add 26.67%38,000
BCRYacktman Fund 2014-06-30 Reduce-0.12%$136.23 - $149.25
($142.86)
$ 168.0115%Reduce -2.76%3,330,000
BCRDonald Yacktman 2014-06-30 Reduce-0.08%$136.23 - $149.25
($142.95)
$ 168.0115%Reduce -1.85%6,701,207
BCRYacktman Focused Fund 2014-06-30 Reduce-0.08%$136.23 - $149.25
($142.95)
$ 168.0115%Reduce -2.13%2,300,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BCR is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BCR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Naughton Gail KDirector 2015-04-28Sell763$170.610.19view
Thompson Tommy GDirector 2015-04-28Sell1,200$170.430.3view
RING TIMOTHY MChairman and CEO 2015-03-23Sell7,628$170.650.17view
BRESLAWSKY MARC CDirector 2015-02-24Sell7,200$174.37-1.97view
RING TIMOTHY MChairman and CEO 2015-02-23Sell20,000$176.33-3.06view
HOLLAND CHRISTOPHER SSenior Vice President and CFO 2015-02-20Sell16,091$176.03-2.89view
DeFord John ASr. VP Sci Tech and Clin Afrs 2015-02-20Sell2,987$174.85-2.24view
WEILAND JOHN HPresident and COO 2015-02-19Sell8,413$174.99-2.31view
Luboff Sharon MGroup Vice President 2015-02-19Sell1,117$174.42-2view
Groetelaars John PGroup Vice President 2015-02-19Sell4,566$175.14-2.4view

Press Releases about BCR :

Quarterly/Annual Reports about BCR:

News about BCR:

Articles On GuruFocus.com
Medtronic Inc. (MDT) Dividend Stock Analysis Feb 25 2015 
Reversing a Declining Pattern in Earnings Per Share Feb 24 2015 
Teleflex Declares Its Quarter Four Results Feb 24 2015 
Becton, Dickinson and Co. (BDX) Dividend Stock Analysis Nov 19 2014 
Weekly 52-Week Highs Highlight: LBTYK, STZ, FISV, BCR Nov 09 2014 
Dividend Aristocrats In Focus Part 19 of 54: CR Bard Oct 15 2014 
Medtronic Inc. (MDT) Dividend Stock Analysis Sep 12 2014 
Paulson, Mindich and Soros Bought Covidien; Should You? Sep 11 2014 
No More a Simple Distributor Sep 07 2014 
Becton, Dickinson and Co. (BDX) Dividend Stock Analysis May 30 2014 

More From Other Websites
BARD C R INC /NJ/ Financials Apr 30 2015
Boston Scientific (BSX) Earnings Report: Q1 2015 Conference Call Transcript Apr 28 2015
BARD C R INC /NJ/ Files SEC form 10-Q, Quarterly Report Apr 24 2015
C.R. Bard (BCR) Q1 Earnings, Sales Top; Currency Woes Stay - Analyst Blog Apr 24 2015
CR Bard (BCR) Earnings Report: Q1 2015 Conference Call Transcript Apr 24 2015
C R Bard Inc Earnings Call scheduled for 5:00 pm ET today Apr 23 2015
Bard Announces First Quarter Results Apr 23 2015
C.R. Bard tops Street 1Q forecasts Apr 23 2015
BARD C R INC /NJ/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Apr 23 2015
Bard Announces First Quarter Results Apr 23 2015
Q1 2015 C R Bard Inc Earnings Release - After Market Close Apr 23 2015
C. R. Bard (BCR) Q1 Earnings: Lutonix DCB Holds the Key - Analyst Blog Apr 21 2015
3 Stocks Breaking Out on Unusual Volume Apr 17 2015
BARD C R INC /NJ/ Files SEC form 8-K, Change in Directors or Principal Officers, Submission of... Apr 17 2015
Bard Declares Quarterly Dividend Apr 15 2015
Bard Declares Quarterly Dividend Apr 15 2015
BARD C R INC /NJ/ Files SEC form 8-K, Other Events Apr 09 2015
Bard to Host Earnings Conference Call on April 23, 2015 Apr 01 2015
Bard to Host Earnings Conference Call on April 23, 2015 Apr 01 2015
CryoLife, CR Bard War over Patent Infringement Continues - Analyst Blog Mar 13 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK